CDTX Financials
Cidara Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$6.96B
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$1.27M
Gross Profit
-
Operating Income
-
Net Income
$-169.83M
EPS (Diluted)
$-26.75
Balance Sheet Highlights
Total Assets
$214.80M
Total Liabilities
$51.49M
Shareholders Equity
-
Cash & Equivalents
$189.82M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-176.53M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CDTX revenue?
CDTX's most recent quarterly revenue was $1.27M. Annual revenue can be calculated by summing the four most recent quarters.
Is CDTX profitable?
CDTX reported a loss of $169.83M in the most recent quarter.
What is CDTX market cap?
CDTX has a market capitalization of $6.96B, making it a mid-cap stock.
Does CDTX have debt?
View CDTX's balance sheet for debt information.
What is CDTX cash flow?
Cash flow data is available in the full financial statements.